(Q40916503)

24 September 2017

title

Apolipoprotein E genotype and gender influence response to tacrine therapy (English)

1 reference

24 September 2017

1

Farlow MR

1 reference

24 September 2017

Lahiri DK

2

1 reference

24 September 2017

Poirier J

series ordinal

3

1 reference

24 September 2017

Davignon J

series ordinal

4

1 reference

24 September 2017

Hui S

series ordinal

5

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

Annals of the New York Academy of Sciences

24 September 2017

published in

1 reference

24 September 2017

volume

802

1 reference

24 September 2017

page(s)

101-110

1 reference

Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB32603.X

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB32603.X

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB32603.X

Apolipoprotein E genotype and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB32603.X

Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB32603.X

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB32603.X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB32603.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB32603.X

Apolipoprotein E polymorphism and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB32603.X

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB32603.X

Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB32603.X

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB32603.X

Apolipoprotein E genotype in patients with alzheimer's disease: Implications for the risk of dementia among relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB32603.X

Alzheimer's disease, apolipoprotein E4, and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB32603.X

APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB32603.X

10.1111/J.1749-6632.1996.TB32603.X

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference